Search

everythinglearnresearchcommunity

for

Search:↓

The oral contraceptive ethinylestradiol/chlormadinone acetate is effective in reducing acne and improving other skin conditions related to high androgen levels.

Higher insulin levels are linked to larger ovaries in women with idiopathic hirsutism.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

The document says that hair loss in women is often due to androgenic alopecia, similar to male baldness, and that hirsutism is treated with hormonal and cosmetic methods.

Surgical removal of a rare ovarian tumor improved symptoms and hormone levels in a postmenopausal woman.

PCOS is a complex condition with major health impacts, needing more research for better diagnosis and treatment.

Women with PCOS have different levels of certain fats and proteins in their blood, which could help diagnose the condition.

Insulin resistance in women with PCOS can lead to serious health issues, but lifestyle changes and certain medications can help manage symptoms.

Birth control pills combined with bicalutamide are more effective at reducing excessive hair growth in women with PCOS than birth control pills alone.

Overweight women with PCOS are more likely to have excess male hormones.

Skin problems in patients with polycystic ovarian disease are linked to body weight, blood sugar, and hormone levels.

Hormonal imbalances in Polycystic Ovarian Syndrome (PCOS) might trigger a rare skin disorder called Confluent and Reticulated Papillomatosis (CRP), so dermatologists should consider checking for PCOS in CRP patients.

PCOS is often linked with menstrual issues, hormonal imbalances, and a higher risk of heart disease and diabetes.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

Mutations in mitochondrial DNA might significantly contribute to the development of Polycystic Ovarian Syndrome.

The modified Ferriman-Gallwey method is a useful tool for diagnosing hirsutism.

About 7% to 15% of Iranian women have polycystic ovary syndrome, depending on the criteria used to diagnose it.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

The document concludes that certain genetic mutations and dietary factors are involved in acne development, and treatments like isotretinoin and diet changes can help manage it.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

FPHL is a common, age-related, genetic hair loss with unclear causes and limited treatment options.

Obese women with PCOS show a male-like pattern in certain fat tissue gene expressions.

The document concludes that more research is needed to understand excessive hair growth in women with normal hormone levels and regular ovulation.

Certain hormone treatments can improve acne and related conditions in women.

Nonclassic congenital adrenal hyperplasia is a genetic disorder causing hormone imbalances, affecting fertility and requiring personalized treatment.

The document concludes that diagnosing and treating Congenital Adrenal Hyperplasia is complex and requires a team approach due to its effects on the skin and other symptoms.

Unwanted facial hair significantly impacts over 40% of women's psychological and social well-being, and various treatment options are available.

The document concludes that Functional Hypothalamic Amenorrhea should be carefully diagnosed and managed to prevent health complications, using lifestyle changes and specific medications.

Primary care for PCOS focuses on lifestyle changes, medication based on symptoms, and mental health, with diabetes screening and specialist referral for severe cases.

Alfacalcidiol and metformin together lowered testosterone in women with PCOS, but did not significantly improve acne, hair growth, or pregnancy rates.